Navigation Links
Protein researches closing in on the mystery of schizophrenia
Date:4/11/2014

Schizophrenia is a severe disease for which there is still no effective medical treatment. In an attempt to understand exactly what happens in the brain of a schizophrenic person, researchers from the University of Southern Denmark have analyzed proteins in the brains of rats that have been given hallucinogenic drugs. This may pave the way for new and better medicines.

Seven per cent of the adult population suffers from schizophrenia, and although scientists have tried for centuries to understand the disease, they still do not know what causes the disease or which physiological changes it causes in the body. Doctors cannot make the diagnosis by looking for specific physiological changes in the patient's blood or tissue, but have to diagnose from behavioral symptoms.

In an attempt to find the physiological signature of schizophrenia, researchers from the University of Southern Denmark conducted tests on rats, and they now believe that the signature lies in some specific, measurable proteins. Knowing these proteins and comparing their behaviour to proteins in the brains of not schizophrenic people may make it possible to develop more effective drugs.

It is extremely difficult to study brain activity in schizophrenic people, which is why researchers often use animal models in their strive to understand the mysteries of the schizophrenic brain. Rat brains resemble human brains in so many ways that it makes sense to study them if one wants to learn more about the human brain.

The strong hallucinogenic drug phenocyclidine (PCP), also known as angel's dust, provides a range of symptoms in people which are very similar to schizophrenia.

"When we give PCP to rats, the rats become valuable study objects for schizophrenia researchers", explains Ole Nrregaard Jensen, professor and head of Department of Biochemistry and Molecular Biology.

Together with Pawel Palmowski, Adelina Rogowska-Wrzesinska and others from a.o. Danish Technological Institute, he is the author of a scientific paper about the discovery, published in the international Journal of Proteome Research.

Among the symptoms and reactions that can be observed in both humans and rats are changes in movement and reduced cognitive functions such as impaired memory, attention and learning ability.

"Scientists have studied PCP rats for decades, but until now no one really knew what was going on in the rat brains on a molecular level. We now present what we believe to be the largest proteomics data set to date", says Ole Nrregaard Jensen.

PCP is absorbed very quickly by the brain, and it only stays in the brain for a few hours. Therefore, it was important for researchers to examine the rat brain cells soon after the rats were injected with the hallucinogenic drug.

"Already after 15 minutes we could see changes in the proteins in the brain, and after 240 minutes it was almost over", says Ole Nrregaard Jensen.

The University of Southern Denmark holds some of the world's most advanced equipment for studying proteins, and Ole Nrregaard Jensen and his colleagues used the university's so-called mass spectrometers for their protein studies.

"We found 2604 proteins, and we saw changes in 352 of them, that can be associated with the PCP injections. These 352 proteins will be extremely interesting to study in more detail to see if they are also altered in people with schizophrenia - and if that's the case, then it will of course be interesting to try to develop a drug that can prevent the protein changes that lead to schizophrenia", says Ole Nrregaard Jensen about the discovery and the work that now lies ahead.

The 352 proteins in rat brains responded immediately when the animals were exposed to PCP. Roughly speaking, the drug made proteins turn on or off when they should not turn on and off. This started a chain reaction of other disturbances in the molecular network around the proteins, such as changes in metabolism and calcium balance.

"It is these 352 proteins that cause the rats to change their behavior - and the events are probably comparable to the devastating changes in a schizophrenic brain", explains Ole Nrregaard Jensen.

The protocol for studying rat brain proteins with mass spectrometry, developed by Ole Nrregaard Jensen and his colleagues, is not limited to schizophrenia studies - it can also be used to explore other diseases.


'/>"/>

Contact: Birgitte Svennevig
birs@sdu.dk
University of Southern Denmark
Source:Eurekalert

Related medicine news :

1. Scaffolding protein promotes growth and metastases of epithelial ovarian cancer
2. Cancer researchers find key protein link
3. Velcro protein found to play surprising role in cell migration
4. Scientists discover new protein involved in lung cancer
5. Brain cell activity regulates Alzheimer’s protein
6. Tumors light up with new, unique imaging system using scorpion venom protein and a laser
7. Study in fruitflies strengthens connection among protein misfolding, sleep loss, and age
8. NUS researchers make new discovery of protein as a promising target for treatment of ATC
9. A new target for cancer and diabetes: A novel role for the adaptor protein p66shc in regulating glucose metabolism
10. Exon skipping prevents formation of toxic protein fragments in Huntingtons disease
11. First observation of a human HAT, key proteins in numerous pathologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 2016 , ... Thermi™, a world leader in thermistor-regulated energy ... promotions of Allison Kelly to executive vice president of the company’s new North ... North American capital sales, and Wendy Oseas to vice president of global marketing. ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... motivational speaker, trainer and author Ray Clarke poses a question as a challenge ... . In his book, "Being in the Being" (published by Partridge Singapore), Clarke ...
(Date:2/11/2016)... ... February 11, 2016 , ... AccuVein Inc. announces the Infusion ... of Practice, to include vascular visualization as a standard practice. AccuVein ( http://www.accuvein.com ... the market, facilitates adherence to this standard with its easy to use, widely ...
(Date:2/11/2016)... ... February 11, 2016 , ... Pixel Film Studios brings ... with customizable backdrops in the Christmas edition of the ProDrop series. Pick and choose ... audiences and invoke the spirit of Christmas using ProDrop's wintry generators. ProDrop Christmas is ...
(Date:2/11/2016)... ... February 11, 2016 , ... Food Labeling for American ... and wellness best practices in the past couple of decades, and food manufacturers ... Heart Month, which acts as an exceptional opportunity to revise food labels and ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... WILMINGTON, N.C. , Feb. 11, 2016 /PRNewswire/ ... a leading provider of custom manufacturing and development ... announces expanded sterile fill-finish capabilities and capacity in ... Substantial growth in demand has driven several recent ... in 2001 it had one filling line with ...
(Date:2/11/2016)... , 11 de fevereiro de 2016 /PRNewswire/ ... de sua fábrica de soroalbumina bovina (BSA -- ... A fábrica fica na Ilha Norte da Nova ... desenvolvido e estabelecido na fábrica da Proliant nos ... . O projeto e instalação dos equipamentos foram ...
(Date:2/11/2016)... February 11, 2016 Breast Cancer Therapeutics ... Asia-Pacific (APAC) breast cancer market will ... billion by 2021, at a Compound Annual Growth Rate (CAGR) ... Markets to 2021 - states that the ... expansion from $1.9 billion in 2014 to $3.4 billion by ...
Breaking Medicine Technology: